ad image

Oneness Biotech

1 / 1
LEO Pharma
Licensing

LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate

LEO Pharma

PR-M04-20-NI-023Apr 15, 2020
1 / 1